Methods and compositions for improved delivery via ultrasound

TW202633667APending Publication Date: 2026-08-16SONOTHERA INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114144737
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-10-06
Filing Date
2025-11-17
Publication Date
2026-08-16

Smart Images

  • Figure TWG2TA001073023_001
    Figure TWG2TA001073023_001
  • Figure TWG2TA001073023_002
    Figure TWG2TA001073023_002
  • Figure TWG2TA001073023_003
    Figure TWG2TA001073023_003
Patent Text Reader

Abstract

Provided are methods and compositions for expressing a functional dystrophin protein or a functional fragment thereof in a subject. The method can include administering a nucleic acid encoding the dystrophin protein to the subject, administering a sonoactive agent to the subject, and applying ultrasound energy the cell. Also provided are use of a nucleic acid encoding a functional dystrophin protein and a sonoactive agent in a method of treating a subject having a dystrophinopathy disorder requiring a dystrophin gene therapy or a dystrophin protein replacement therapy.
Need to check novelty before this filing date? Find Prior Art